The use of epigenetic modulators (DNA methylation and H3K27 trimethylation inhibitors) restored the tumoural expression of CXCL9 and CXCL10, enhancing CAR T cell efficacy in a murine model of ovarian cancer, with improved T cell infiltration and tumour growth control [49]. The gene discussed is CXCL10; the disease is neoplasm.